RNU1-41P

Across TCGA pan-cancer cohorts, RNU1-41P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU1-41P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU1-41P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-41P expression acts as an unfavorable survival marker.

OV, BRCA, and ESCA are the cancer types where RNU1-41P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.353	0.551	<.001	54	view →
BRCA	DFS	Tertile	All	0.321	0.903	<.001	36	view →
ESCA	DFS	Tertile	III,IV	0.103	0.442	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU1-41P–OV (DFS)

Open the OV breakdown →